Effective drug regulation a multicountry study. (Record no. 1897)

MARC details
000 -LEADER
fixed length control field 01791nam a22002297a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20191226214707.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 110914t xxu||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9241562064
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 33 E 2002
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ratanawijitrasin, Sauwakon.
9 (RLIN) 4739
245 10 - TITLE STATEMENT
Title Effective drug regulation a multicountry study.
Statement of responsibility, etc. Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Geneva :
Name of publisher, distributor, etc. World Health Organization,
Date of publication, distribution, etc. 2002.
300 ## - PHYSICAL DESCRIPTION
Extent ix, 142 p. :
Other physical details ill. ;
Dimensions 30 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references (p. 141-142).
520 ## - SUMMARY, ETC.
Summary, etc. Drugs play a crucial role in saving lives, restoring health, and preventing diseases and epidemics. But they need to be safe, efficacious, of good quality, and used rationally. This means that their production, import/export, storage, supply and distribution should be subject to government control through prescribed norms and standards and an effective regulatory system. Substandard and counterfeit drugs proliferate primarily in an environment where drug regulation has proved ineffective.<br/><br/>This publication presents a synthesis of studies on drug regulation carried out in 10 countries: Australia, Cuba, Cyprus, Estonia, Malaysia, the Netherlands, Tunisia, Uganda, Venezuela, and Zimbabwe in 1998-1999. It gives an overview of the development of drug regulation in these countries as well as the resources available and the strategies applied in drug regulation implementation at the time the studies were conducted. An analysis of the strengths and weaknesses in drug regulation in these countries is also provided.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical policy
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drugs
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wondemagegnehu, Eshetu.
9 (RLIN) 4742
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme National Library of Medicine Classification
Koha item type WHO Publications
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type Date last checked out
    National Library of Medicine Classification     FNPH LIBRARY FNPH LIBRARY 14/09/2011   QV 33 E 2002 02858 14/09/2011 14/09/2011 WHO Publications  
    National Library of Medicine Classification     FNPH LIBRARY FNPH LIBRARY 30/11/2011 2 QV 33 E 2002 03612 29/11/2021 30/11/2011 WHO Publications 26/10/2021
NEW ARRIVALS (Click to the book jackets to see its bibliographic details)



© 2022 All Rights Reserved, Faculty of Nursing and Public Health

Khesar Gyalpo University of Medical Sciences of Bhutan (KGUMSB), Thimphu
Telephone: +975-2-322031 (Ext.140)
Email: library@fnph.edu.bt